Related Experiment Videos
Hypersensitivity reactions to parenteral lipid solutions
B Weidmann1, C Lepique, A Heider
1Department of Oncology and Hematology, Klinikum Leverkusen, Germany.
Summary
Hypersensitivity reactions in cancer patients receiving intravenous therapy may be misdiagnosed. Soybean proteins in lipid emulsions, not the fatty acids, may trigger these severe systemic reactions.
Area of Science:
- Oncology
- Clinical Immunology
- Pharmacology
Background:
- Hypersensitivity reactions to adjunctive medications in cancer patients can mimic cytostatic toxicities.
- Accurate diagnosis is crucial for appropriate patient management and treatment efficacy.
Observation:
- Three cancer patients experienced systemic reactions (flush, dyspnea, tachycardia, hypotension, back pain) during intravenous therapy.
- Reactions occurred with lipid emulsions containing long-chain fatty acids (LCT).
Findings:
- Subsequent exposure to LCT and medium-chain fatty acid (MCT) solutions, without soybean lecithin, was well tolerated.
- These findings suggest that trace amounts of soybean proteins, rather than the fatty acids themselves, are the likely allergenic agents.
Implications:
- Hypersensitivity to medications, including parenteral nutrition, should be considered in cancer patients with severe systemic reactions.
- Differentiating drug reactions from treatment toxicity is essential for optimizing cancer care and preventing adverse events.